ArticleJournal of molecular medicine (Berlin, Germany)2018

Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.

Manas R Biswal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.